Skip to main content

Search

Center for Clinical and Translational Research

The Center for Clinical and Translational Research (CCTR) plays an integral role in transforming scientific discoveries into real-world therapies that prevent and treat childhood illness and improve the quality of children’s daily lives. Learn more about the CCTR.

Programs and Resources for Researchers

CCTR’s programs, facilities and services help ensure researchers within the center – and throughout Children’s – have the means and the opportunity to conduct safe, efficient, and ethical research involving children.

Participate in Research

Participants in clinical studies can play a more active role in their own healthcare, gain access to new research treatments before they are widely available and help others by contributing to medical research. Learn more about clinical trials and research programs in the CCTR.

 

Watch this video to learn more about the integration of research and clinical care at Seattle Children's.

Key Partnerships

Partnerships are a key part of the CCTR mission. Our researchers collaborate with their colleagues at Seattle Children’s, across the nation and around the world in pursuit of innovative health solutions.

 

CCTR is the pediatric home of the Institute of Translational Health Sciences, and we partner regularly with the University of Washington and Fred Hutchinson Cancer Research Center.

Publications

Stay Informed

Our Experts in the Media

  • Doctor’s Advice: How to enjoy the hot weather safely
    07.11.2014 – Q13 FOX
    Dr. Tony Woodward discusses how to enjoy the hot weekend weather safely. Everyone wants to enjoy the nice weather lately, but as temperatures rise moderation becomes more and more important.
  • Less invasive approach to treat concave chests
    07.08.2014 – KING 5 News
    Imagine being a teenager not having enough energy to even take a walk because your chest is sinking. The condition affects one in 400 kids, but only a minority of those will need surgery. Jean Enersen shows us a less invasive approach to fixing the problem. Dr. Patrick Javid and Dr. Robert Sawin were featured in this segment.
  • Two 24-Week Phase 3 Studies of Lumacaftor in Combination with Ivacaftor Met Primary Endpoint with Statistically Significant Improvements in Lung Function (FEV1) in People with Cystic Fibrosis who have Two Copies of the F508del Mutation
    6.24.2014 – Business Wire
    Phase 3 clinical trials of ivacaftor (Kalydeco™) in combination with lumacaftor (VX-809) for people with two copies of the F508del mutation of cystic fibrosis showed significant improvements in lung function and other key measures of the disease, according to Vertex Pharmaceuticals Inc. Dr. Bonnie Ramsey, of Seattle Children’s Research Institute, is a lead principal investigator for the studies.
  • A Doctor’s Quest to Save People by Injecting Them with Scorpion Venom
    6.24.2014 – Wired
    Because it’s so late on a Monday afternoon, there is a listless vibe inside the University of Washington lecture hall where Dr. Jim Olson of Seattle Children’s is about to speak. Olson’s first slide wakes them up. It is a pixelated photograph of an adorable 6-year-old boy named Hayden Strum, who suffered from a pernicious brain tumor and came to Olson in 1995, when Olson was just starting his career. Olson tells the students that he finally has a solution to what Hayden went through: Tumor Paint, a scorpion-venom concoction that makes tumors glow that sounds almost too outlandish to be true.
  • Class of 2014: After transplant, teen has a new heart and new horizons
    06.08.2014 – The Herald (Everett)
    Micaela Powell walked from her Madison neighborhood home to nearby stores last week, an 18-year-old in search of a summer job. It took her more than an hour to walk the one-and-a-half-mile loop. Even at this distance, it was a milestone, the longest walk of her life. Doctors at Seattle Children's first presented the idea of a heart transplant about five years ago. “It took her a while to come around, to be convinced that she needed one,” said Dr. Erin Albers, a transplant cardiologist at Seattle Children's.
  • Just what the doctor ordered – Surface Pro 3
    6.3.2014 – Microsoft UK Health Blog
    At Seattle Children’s, Surface Pro 3 will be the laptop replacement for doctors and officials for a number of reasons. Among them, says Dr. Maida Chen, director of the Pediatric Sleep Center, the Surface Pro 3 pen and the ability to take notes on the device’s 12-inch screen are a huge plus. “When we have very quickly evolving situations with patients, jotting down notes is still the way that most clinicians go,” she says in a video.

Careers

Developing innovative treatments to potentially prevent and cure childhood illnesses takes more than just the right ideas. It also takes the right people. We are constantly seeking experienced leaders and enthusiastic emerging professionals who embrace collaboration and are committed to improving child health.

 

Does that sound like you? Please visit Seattle Children's careers page to find your perfect career in the CCTR.

Contact Us

 

Email CCTR

206-884-7469

 

2001 Eighth Ave, Suite 400

Mailstop: CW8-5B

Seattle, WA 98121

Looking for a Researcher?

Looking for a researcher?

Name: